Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ndt/gfr627PMID 22123748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial

  2010cited by this paper
• Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients

  2010cited by this paper
• First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

  2010cited by this paper
• Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.

  2010cited by this paper
• Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

  2009cited by this paper
• Minimizing the Risk of Posttransplant Malignancy

  2009cited by this paper
• BK virus nephritis after renal transplantation.

  2008cited by this paper
• Reduced exposure to calcineurin inhibitors in renal transplantation.

  2008cited by this paper
• HLA Mismatches Remain Risk Factors for Acute Kidney Allograft Rejection in Patients Receiving Quadruple Immunosuppression With Anti-Interleukin-2 Receptor Antibodies

  2008cited by this paper
• Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.

  2008cited by this paper
• Reduced exposure to calcineurin inhibitors in renal transplantation.

  2007cited by this paper
• Mycophenolate Mofetil Inhibits Tumor Growth and Angiogenesis In Vitro but Has Variable Antitumor Effects In Vivo, Possibly Related to Bioavailability

  2007cited by this paper
• Cancer incidence before and after kidney transplantation.

  2006cited by this paper
• Subsequent Skin Cancers in Kidney and Heart Transplant Recipients after the First Squamous Cell Carcinoma

  2006cited by this paper
• Post‐transplant de novo malignancies in renal transplant recipients: the past and present

  2006cited by this paper
• Disassociation Between Risk of Graft Loss and Risk of Non-Hodgkin Lymphoma With Induction Agents in Renal Transplant Recipients

  2006influential reference
• Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

  2005cited by this paper
• Prospective Registry‐Based Observational Cohort Study of the Long‐Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil

  2005cited by this paper
• Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage

  2005cited by this paper
• Cancer after Kidney Transplantation in the United States

  2004influential reference
• Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

  2004influential reference
• PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION

  2004cited by this paper
• Incidence of cancer after kidney transplant: results from the North Italy transplant program

  2003cited by this paper
• Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1

  2003cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Malignancy after renal transplantation: Incidence and role of type of immunosuppression

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

  2000cited by this paper
• The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

  2000cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• Patterns of malignancies following renal transplantation.

  1999cited by this paper
• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.

  1998cited by this paper
• A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

  1998cited by this paper
• A Blinded, Long-term, Randomized Multicenter Study Of Mycophenolate Mofetil In Cadaveric Renal Transplantation: Results at Three Years1,2

  1998cited by this paper
• Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome.

  1992cited by this paper
• UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )

  year unknowncited by this paper

• Genotoxicity and mutagenicity of emerging mycotoxins: a systematic review

  2025cites this paper
• De novo colorectal cancer after kidney transplantation: a systematic review and meta-analysis

  2025cites this paper
• Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients.

  2023cites this paper
• Investigation of Underlying Biological Association and Targets between Rejection of Renal Transplant and Renal Cancer

  2023cites this paper
• Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy

  2023cites this paper
• Immunomodulatory Effect of Hispolon on LPS-Induced RAW264.7 Cells and Mitogen/Alloantigen-Stimulated Spleen Lymphocytes of Mice

  2022cites this paper
• Enfermedadlinfoproliferativa difusa postrasplanterenal: Estudiolonguitudinalde 21.546 receptores durante 2 decadas en España

  2022cites this paper
• Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling

  2020cites this paper
• Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients.

  2017cites this paper
• Operational tolerance in kidney transplantation and associated biomarkers

  2017cites this paper
• Periocular Skin Cancer in Solid Organ Transplant Recipients.

  2016cites this paper
• Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation

  2016cites this paper
• Early post-transplant lymphoproliferative disorder – Case of fatal lymphoma after kidney transplantation.

  2016cites this paper
• Kidney transplantation in patients with history of malignancy: Time to rethink the guidelines?

  2015cites this paper
• Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations

  2015cites this paper
• Overview on non-melanoma skin cancers in solid organ transplant recipients.

  2014cites this paper
• Current Pathways for Immune Manipulation

  2014cites this paper
• A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic

  2014cites this paper
• Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients

  2012influential citation
• Burden of de novo malignancy in the liver transplant recipient

  2012cites this paper
• Sicherheit der Immunsuppressiva

  2012cites this paper
• Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients

  2012cites this paper